TY - JOUR
T1 - Opportunities and barriers in the age of team science
T2 - strategies for success
AU - Sellers, Thomas A.
AU - Caporaso, Neil
AU - Lapidus, Stan
AU - Petersen, Gloria M.
AU - Trent, Jeff
PY - 2006/4
Y1 - 2006/4
N2 - Objective: To provide the voice of experience to investigators contemplating engagement in the realm of "team science". Methods: Leaders were brought together from academia, government, and industry to share perspectives and insights based on real-life experiences. A panel discussion was held at the 2005 annual meeting of the American Association of Cancer Research. This article summarizes that forum. Results: The panel focused on eight specific topics that were determined in advance to be the most important: the main justification for team science, funding team science, pre-arranged versus assigned partnerships, the role of novel technology with industrial partners, recognition for efforts and contribution in team science, budgets, keys to success when bridging disciplines and cultures, and balancing goals between academia and business. Although there were some differences of opinion, there were also a number of areas of agreement. Many practical suggestions were provided on how to succeed in the age of team science. Principal conclusion: The nature of scientific discovery in cancer research is increasingly requiring team science. Understanding the perspectives of academia, government, and business in this new world order is essential to successful navigation and, ultimately, major accomplishment in the effort to defeat the disease.
AB - Objective: To provide the voice of experience to investigators contemplating engagement in the realm of "team science". Methods: Leaders were brought together from academia, government, and industry to share perspectives and insights based on real-life experiences. A panel discussion was held at the 2005 annual meeting of the American Association of Cancer Research. This article summarizes that forum. Results: The panel focused on eight specific topics that were determined in advance to be the most important: the main justification for team science, funding team science, pre-arranged versus assigned partnerships, the role of novel technology with industrial partners, recognition for efforts and contribution in team science, budgets, keys to success when bridging disciplines and cultures, and balancing goals between academia and business. Although there were some differences of opinion, there were also a number of areas of agreement. Many practical suggestions were provided on how to succeed in the age of team science. Principal conclusion: The nature of scientific discovery in cancer research is increasingly requiring team science. Understanding the perspectives of academia, government, and business in this new world order is essential to successful navigation and, ultimately, major accomplishment in the effort to defeat the disease.
KW - Biotechnology
KW - Epidemiologic studies
KW - Interdisciplinary communication
KW - Neoplasms
UR - http://www.scopus.com/inward/record.url?scp=32944471554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=32944471554&partnerID=8YFLogxK
U2 - 10.1007/s10552-005-0546-5
DO - 10.1007/s10552-005-0546-5
M3 - Review article
C2 - 16489530
AN - SCOPUS:32944471554
SN - 0957-5243
VL - 17
SP - 229
EP - 237
JO - Cancer Causes and Control
JF - Cancer Causes and Control
IS - 3
ER -